On Thursday, the Food and Drug Administration approved the antiviral drug remdesivir for patients with COVID-19 severe enough to require hospitalization. Remdesivir has been on the Emergency Use Authorization (EUA) list for COVID-19 patients since May 1, 2020.
Read More News